Tucson-based Cancer Prevention Pharmaceuticals Inc. has signed an exclusive licensing agreement with a Swiss drug company for European and Japanese rights to develop and commercialize a gastrointestinal-cancer-prevention drug.
University of Arizona economics junior Nick Palomares, 21, in his bedroom at his parents' house on Tucson's east side. Palomares was diagnosed with testicular cancer last year and was forced to withdraw from class this semester to move back home when the cancer spread.
University of Arizona economics junior Nick Palomares keeps a positive attitude while working with phlebotomist Nicy Perez, who is drawing his blood for analysis before an appointment with his oncologist.
Nearly two decades ago, University of Arizona radiologist Dr. Evan Unger recognized that an ultrasound imaging contrast agent he pioneered held promise as a way to deliver drugs or therapies to specific areas.